Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer.
Authors
Kaufmann, Andreas MStern, Peter L
Rankin, Elaine M
Sommer, Harald
Nuessler, Volkmar
Schneider, Achim
Adams, Malcolm
Onon, Toli S
Bauknecht, Thomas
Wagner, Uwe
Kroon, Karlijn
Hickling, Julian K
Boswell, Christopher M
Stacey, Simon N
Kitchener, Henry C
Gillard, Jennifer
Wanders, Jantien
Roberts, John St C
Zwierzina, Heinz
Affiliation
Frauenklinik, Friedrich-Schiller-University of Jena, 07743 Jena, Germany. a.kaufmann@med.uni-jena.deIssue Date
2002-12